BAP1 loss in the diagnosis of malignant mesothelioma; review of a regional mesothelioma MDT
H. Mcdill (Bristol (Avon), United Kingdom), A. Dipper (Bristol (Avon), United Kingdom), N. Bhatt (Bristol (Avon), United Kingdom), A. Clive (Bristol (Avon), United Kingdom), N. Maskell (Bristol (Avon), United Kingdom), A. Bibby (Bristol (Avon), United Kingdom)
Source: International Congress 2022 – Pleural and thymic malignancies: from bench to bedside
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Mcdill (Bristol (Avon), United Kingdom), A. Dipper (Bristol (Avon), United Kingdom), N. Bhatt (Bristol (Avon), United Kingdom), A. Clive (Bristol (Avon), United Kingdom), N. Maskell (Bristol (Avon), United Kingdom), A. Bibby (Bristol (Avon), United Kingdom). BAP1 loss in the diagnosis of malignant mesothelioma; review of a regional mesothelioma MDT. 429
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|